"One in six American adults lives with high cholesterol https and millions have trouble getting it under control according to the Centers for Disease Control and Prevention http Now researchers believe a a new type of experimental drug may help change that. Researchers analyzed  randomized control trials to assess the efficacy and safety of the new drugs called PCSK antibodies in adults with high cholesterol levels. The antibodies target the cholesterolregulating protein PCSK and lower the levels of LDL the socalled bad cholesterol by  percent.  The results published in the Annals of Internal Medicine httpannals.orgarticle.aspxarticleid also show that the drugs have a significant effect on reducing heart attacks and overall mortality. It seems that the group that takes them compared to the group that doesnt has half the rate of cardiovascular events and mortality as those that dont Dr. Seth S. Martin of the Johns Hopkins School of Medicine http told CBS News. Current guidelines https suggest cholesterol be treated with statins a class of drugs that inhibit an enzyme that plays an important role in the production of cholesterol in the liver. But some patients cant tolerate the side effects which can include headache difficulty sleeping muscle aches diarrhea constipation and nausea or vomiting.  Others have such high cholesterol that taking statins alone is not enough. These new drugs could be for someone who needs an addition to statin or it could be instead of statin Martin said. In an editorial published along with the study experts note that although the results are promising more longterm research is needed to make definitive conclusions about the drug."